Overview and Scope
Single nucleotide polymorphism (SNP) genotyping refers to a procedure that locates and describes genetic variants at the level of specific DNA nucleotides. It identifies individual SNPs, which are single-base changes in DNA sequences, and it is essential for understanding the genetic variations linked to diseases, traits, and population studies.
Sizing and Forecast
The single nucleotide polymorphism (snp) genotyping market size has grown exponentially in recent years. It will grow from $8.48 billion in 2023 to $10.24 billion in 2024 at a compound annual growth rate (CAGR) of 20.7%. The growth in the historic period can be attributed to increasing research in genomics, rise in genetic disorders, growth in personalized medicine, expanding pharmaceutical industry, rising demand for molecular diagnostics.
The single nucleotide polymorphism (snp) genotyping market size is expected to see rapid growth in the next few years. It will grow to $20.6 billion in 2028 at a compound annual growth rate (CAGR) of 19.1%. The growth in the forecast period can be attributed to growing applications in disease research, rise in demand for precision medicine, expanding biobanking initiatives, surge in genetic testing, rising adoption in agriculture for crop improvement. Major trends in the forecast period include increasing use of next-generation sequencing (ngs), rising demand for snp genotyping in pharmacogenomics, emergence of direct-to-consumer genetic testing, focus on automation and high-throughput genotyping platforms.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/single-nucleotide-polymorphism-snp-genotyping-global-market-report
Segmentation & Regional Insights
The single nucleotide polymorphism (snp) genotyping market covered in this report is segmented –
1) By Product: Consumables, Instruments, services
2) By Technology: TaqMan SNP Genotyping, Mass Array SNP Genotyping, SNP Gene Chip Arrays, Other Technologies
3) By Application: Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals And Pharmacogenomics, Agricultural Biotechnology, Other Applications
North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single nucleotide polymorphism (snp) genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=12569&type=smp
Major Driver Impacting Market Growth
The increasing burden of chronic conditions is expected to propel the growth of the single nucleotide polymorphism (SNP) genotyping market going forward. Chronic conditions are problems that last a year or longer, necessitating continuing medical care, restricting everyday activities, or both. Single Nucleotide Polymorphism (SNP) genotyping is essential for identifying genetic predispositions and promoting personalized medicine due to the increased prevalence of chronic diseases. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, there will be 142.66 million people with chronic diseases worldwide by the year 2050, up from 71.522 million in 2020. Therefore, the increasing burden of chronic conditions drives the growth of the single nucleotide polymorphism (SNP) genotyping systems market.
Key Industry Players
Major companies operating in the single nucleotide polymorphism (SNP) genotyping market report are Thermo Fischer Scientific Inc., Danaher Corporation, Roche Diagnostics Corporation, GE HealthCare Technologies Inc., Eurofins Genomics LLC, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Sigma-Aldrich Corporation, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Promega Corporation, GenScript Biotech Corporation, Integrated DNA Technologies Inc., LGC Ltd., Sequenom Inc., Fluidigm Corporation, Agendia Inc., Nugen Technologies Inc., BioChain Institute Inc., Standard BioTools Inc., Oxford Gene Technology, Affymetrix Inc., PREMIER Biosoft International Inc., GenoLogics, Rubicon Genomics Inc., Xcelris Genomics, Douglas Scientific LLC, Golden Helix Inc.
The single nucleotide polymorphism (snp) genotyping market report table of contents includes:
1. Executive Summary
2. Single Nucleotide Polymorphism (SNP) Genotyping Market Characteristics
3. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends And Strategies
4. Single Nucleotide Polymorphism (SNP) Genotyping Market – Macro Economic Scenario
5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth
.
.
.
31. Single Nucleotide Polymorphism (SNP) Genotyping Market Other Major And Innovative Companies
32. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Benchmarking
33. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Single Nucleotide Polymorphism (SNP) Genotyping Market
35. Single Nucleotide Polymorphism (SNP) Genotyping Market Future Outlook and Potential Analysis
36.Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
